Quick Answer
BIO-TECHNE Corp reported Gross Profit of $790.27 million for the year ending 2025.
- BIO-TECHNE Corp showed an increase of +2.7% in Gross Profit from 2024 to 2025.
- This data is from BIO-TECHNE Corp's annual report (Form 10-K), filed with the SEC on August 22, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2010: $55.88 million | Q3 2010: $52.60 million | Q4 2010: $52.38 million | Q1 2011: $60.33 million | Q3 2011: $58.39 million | Q4 2011: $55.17 million | Q1 2012: $63.38 million | Q3 2012: $55.58 million | Q4 2012: $55.26 million | Q1 2013: $61.15 million | Q3 2013: $61.11 million | Q4 2013: $58.59 million | Q1 2014: $68.11 million | Q3 2014: $73.07 million | Q4 2014: $75.74 million | Q1 2015: $79.38 million | Q3 2015: $75.39 million | Q4 2015: $81.59 million | Q1 2016: $89.99 million | Q3 2016: $87.35 million | Q4 2016: $88.14 million | Q1 2017: $96.68 million | Q3 2017: $97.87 million | Q4 2017: $101.83 million | Q1 2018: $110.26 million | Q3 2018: $107.60 million | Q4 2018: $113.02 million | Q1 2019: $124.61 million | Q3 2019: $118.41 million | Q4 2019: $121.40 million | Q1 2020: $130.06 million | Q3 2020: $137.73 million | Q4 2020: $150.90 million | Q1 2021: $168.27 million | Q3 2021: $171.00 million | Q4 2021: $183.69 million | Q1 2022: $201.46 million | Q3 2022: $179.60 million | Q4 2022: $183.36 million | Q1 2023: $202.16 million | Q3 2023: $185.19 million | Q4 2023: $176.59 million | Q1 2024: $204.60 million | Q3 2024: $183.02 million | Q4 2024: $193.89 million | Q1 2025: $214.56 million | Q3 2025: $188.11 million | Q4 2025: $191.28 million.
- Over the full 17 years of available data (2009 to 2025), BIO-TECHNE Corp's Gross Profit has grown by 279.9%.
- Historical annual values: Fiscal year 2025: $790.27 million | Fiscal year 2024: $769.73 million | Fiscal year 2023: $769.82 million | Fiscal year 2022: $756.50 million | Fiscal year 2021: $632.85 million | Fiscal year 2020: $483.19 million | Fiscal year 2019: $473.49 million | Fiscal year 2018: $432.14 million | Fiscal year 2017: $374.54 million | Fiscal year 2016: $336.66 million | Fiscal year 2015: $307.28 million | Fiscal year 2014: $251.41 million | Fiscal year 2013: $231.11 million | Fiscal year 2012: $235.80 million | Fiscal year 2011: $224.94 million | Fiscal year 2010: $214.15 million | Fiscal year 2009: $208.03 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: